(Q40837761)

24 September 2017

1 reference

title

Genetic dissection of familial Parkinson's disease (English)

1 reference

24 September 2017

1 reference

Riess O

1

1 reference

PubMed ID

9793932

24 September 2017

Jakes R

series ordinal

2

1 reference

PubMed ID

9793932

24 September 2017

Krüger R

series ordinal

3

1 reference

24 September 2017

1 October 1998

1 reference

Trends in Molecular Medicine

24 September 2017

1 reference

24 September 2017

4

1 reference

24 September 2017

10

1 reference

24 September 2017

438-444

1 reference

24 September 2017

Genes and parkinsonism.

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901343-4

7 January 2021

Anti-ubiquitin immunocytochemistry is more sensitive than conventional techniques in the detection of diffuse Lewy body disease

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901343-4

7 January 2021

The significance of the Lewy body in the diagnosis of idiopathic Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901343-4

7 January 2021

Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901343-4

7 January 2021

Ecogenetics of Parkinson's disease: prevalence and environmental aspects in rural areas

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901343-4

7 January 2021

Parkinson's disease in twins studied with 18F-dopa and positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901343-4

7 January 2021

A susceptibility locus for Parkinson's disease maps to chromosome 2p13.

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901343-4

7 January 2021

Mapping of a gene for Parkinson's disease to chromosome 4q21-q23

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901343-4

7 January 2021

Mutation in the alpha-synuclein gene identified in families with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901343-4

7 January 2021

Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901343-4

7 January 2021

Low frequency of alpha-synuclein mutations in familial Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901343-4

7 January 2021

Failure to find the alpha-synuclein gene missense mutation (G209A) in 100 patients with younger onset Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901343-4

7 January 2021

Sequencing of the alpha-synuclein gene in a large series of cases of familial Parkinson's disease fails to reveal any further mutations. The European Consortium on Genetic Susceptibility in Parkinson's Disease (GSPD)

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901343-4

7 January 2021

Self-oligomerization of NACP, the precursor protein of the non-amyloid beta/A4 protein (A beta) component of Alzheimer's disease amyloid, observed in the presence of a C-terminal A beta fragment (residues 25-35).

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901343-4

7 January 2021

Lewy bodies contain beta-amyloid precursor proteins of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901343-4

7 January 2021

Non-A beta component of Alzheimer's disease amyloid (NAC) is amyloidogenic

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901343-4

7 January 2021

Residues in the synuclein consensus motif of the alpha-synuclein fragment, NAC, participate in transglutaminase-catalysed cross-linking to Alzheimer-disease amyloid beta A4 peptide

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901343-4

7 January 2021

Alpha-synuclein in Lewy bodies

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901343-4

7 January 2021

Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901343-4

7 January 2021

The precursor protein of non-A beta component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901343-4

7 January 2021

Huntingtin localization in brains of normal and Huntington's disease patients

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901343-4

7 January 2021

Machado-Joseph disease gene product is a cytoplasmic protein widely expressed in brain

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901343-4

7 January 2021

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901343-4

1 reference

7 January 2021

Aggregation of neurofilament and alpha-synuclein proteins in Lewy bodies: implications for the pathogenesis of Parkinson disease and Lewy body dementia

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901343-4

7 January 2021

Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901343-4

7 January 2021

The core Alzheimer's peptide NAC forms amyloid fibrils which seed and are seeded by beta-amyloid: is NAC a common trigger or target in neurodegenerative disease?

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901343-4

7 January 2021

Chaperoning brain diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901343-4

7 January 2021

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part IX. A prospective cliniconeuropathologic study of Parkinson's features in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901343-4

7 January 2021

History of dementia and Parkinson's disease in 1st-degree relatives of patients with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901343-4

7 January 2021

Modulation of the age at onset of Parkinson's disease by apolipoprotein E genotypes

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901343-4

7 January 2021

Peptides containing glutamine repeats as substrates for transglutaminase-catalyzed cross-linking: relevance to diseases of the nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901343-4

7 January 2021

Suppression of aggregate formation and apoptosis by transglutaminase inhibitors in cells expressing truncated DRPLA protein with an expanded polyglutamine stretch.

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901343-4

7 January 2021

Intranuclear neuronal inclusions: a common pathogenic mechanism for glutamine-repeat neurodegenerative diseases?

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901343-4

7 January 2021

Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901343-4

7 January 2021

Identification of two distinct synucleins from human brain

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901343-4

7 January 2021

NACP, a protein implicated in Alzheimer's disease and learning, is natively unfolded

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901343-4

7 January 2021

Regulation of phospholipase D2: selective inhibition of mammalian phospholipase D isoenzymes by alpha- and beta-synucleins

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901343-4

7 January 2021

Role of phospholipase D activation in nervous system physiology and pathophysiology

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901343-4

7 January 2021

The synucleins: a family of proteins involved in synaptic function, plasticity, neurodegeneration and disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901343-4

7 January 2021

10.1016/S1357-4310(98)01343-4

Identifiers

DOI

1 reference

24 September 2017

1 reference

PubMed ID

9793932